Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial ...Middle East

HOUSTON, April 6, 2021 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced the engagement of IQVIA Biotech, a...

Hence then, the article about moleculin engages iqvia to manage potential covid 19 clinical trial was published today ( Tuesday 06/04/2021 - 02:46 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial )

Also on site :

• US trade with Southeast Asia and Taiwan surging despite Trump tariffs
• Amazon Is Selling a 'Beautiful' $19 Cherry Blossom Tree Lamp That 'Looks Lovely at Night'
• Netflix Reboots Star Search: Who Won Big On Night 1? And Are You Vibing With The Judges? Grade The Premiere!